SS/Jr |
heart left ventricle fractional shortening |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 29 days) then controlled sodium content diet (4 %) (between 40 and 41 days) |
Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2. |
heart left ventricle end-diastolic diameter |
male |
109 days-112 days |
6 |
|
44.0 |
% |
4.0 |
9.8 |
transthoracic echocardiography |
0 |
|
0 |
|
|
65749 |
283 |
SS.SR-(D3Arb14-D3Mco36)(D7Mco19-D7Mco7)/Mco |
heart left ventricle fractional shortening |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 29 days) then controlled sodium content diet (4 %) (between 40 and 41 days) |
Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2. |
heart left ventricle end-diastolic diameter |
male |
109 days-112 days |
7 |
|
57.0 |
% |
3.0 |
7.94 |
transthoracic echocardiography |
0 |
|
0 |
|
|
65751 |
283 |
SS/JrSeac |
heart left ventricle fractional shortening |
controlled sodium content diet (0.3 %) (for 35 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart left ventricle end-diastolic diameter |
not specified |
77 days
| 5 |
FS=(EDD−ESD)/EDD |
46.0 |
% |
2.91 |
6.5 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
68575 |
733 |
SS/JrSeac |
heart left ventricle fractional shortening |
controlled sodium content diet (8 %) (for 84 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart left ventricle end-diastolic diameter |
not specified |
126 days
| 5 |
FS=(EDD−ESD)/EDD |
23.0 |
% |
2.59 |
5.8 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
68578 |
733 |
SS/Jr |
heart left ventricle fractional shortening |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle end-diastolic diameter |
male |
77 days
| 40 |
(LVDdLVDs)/LVDd x 100 |
50.7 |
% |
0.83 |
5.25 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
68282 |
542 |
SS.LEW-(D18Rat29-D18Rat55)/Ayd |
heart left ventricle fractional shortening |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle end-diastolic diameter |
male |
77 days
| 11 |
(LVDdLVDs)/LVDd x 100 |
47.7 |
% |
1.16 |
3.84 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
68283 |
542 |
SS-Nppbem2Mcwi-/- |
heart left ventricle fractional shortening |
control condition (for 28 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
28 days
| 7 |
|
54.9 |
% |
6.9 |
18.26 |
echocardiography |
0.0 |
|
0 |
|
|
99634 |
2319 |
SS-Nppbem2Mcwi-/- |
heart left ventricle fractional shortening |
control condition (for 56 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
56 days
| 6 |
|
48.3 |
% |
8.1 |
19.84 |
echocardiography |
0.0 |
|
0 |
|
|
99636 |
2319 |
SS-Nppbem2Mcwi-/- |
heart left ventricle fractional shortening |
control condition (for 84 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
84 days
| 10 |
|
47.3 |
% |
4.1 |
12.97 |
echocardiography |
0.0 |
|
0 |
|
|
99638 |
2319 |
SS.ZUC-Leprfa+/+/Slc |
heart left ventricle fractional shortening |
bilateral ovariectomy (for 42 days) then vehicle control condition (for 35 days) |
Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23. |
heart left ventricle end-diastolic diameter |
female |
91 days
| 9 |
|
39.8 |
% |
2.5 |
7.5 |
echocardiography |
0.0 |
ovariectomy |
42 |
days |
|
101719 |
2622 |
WKY |
heart left ventricle fractional shortening |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
238 days-252 days |
20 |
|
15.1 |
% |
1.0 |
4.47 |
echocardiography |
0.0 |
lad occlusion |
196 |
days |
|
100349 |
2460 |
SS-Nppbem2Mcwi-/- |
heart left ventricle fractional shortening |
gene transfer of the rat natriuretic peptide B gene using an adenovirus vector (100000000000 PFU) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
252 days
| 6 |
|
39.2 |
% |
5.8 |
14.21 |
echocardiography |
0.0 |
|
0 |
|
|
99809 |
2319 |
SS.ZUC-Leprfa+/+/Slc |
heart left ventricle fractional shortening |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
heart left ventricle end-diastolic diameter |
male |
91 days
| 8 |
|
32.62 |
% |
1.67 |
4.72 |
echocardiography |
0.0 |
|
0 |
|
|
101805 |
2641 |
SBH/Ygl |
heart left ventricle fractional shortening |
controlled sodium chloride content diet (8 %) (for 42 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 42 days) |
Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040. |
heart left ventricle end-diastolic diameter |
male |
98 days
| 7 |
|
65.0 |
% |
1.0 |
2.65 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
106715 |
3038 |
SS/JrHsdMcwi |
heart left ventricle fractional shortening |
angiotensin II (200 ng/kg/min) (for 14 days) then isoflurane (1-2 %) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
heart left ventricle end-diastolic diameter |
male |
63 days-70 days |
5 |
|
57.2 |
% |
2.7 |
6.04 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
105828 |
3023 |
WKY |
heart left ventricle fractional shortening |
left anterior descending coronary artery occlusion (for 196 days) then vehicle control condition (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
238 days-252 days |
30 |
|
15.8 |
% |
0.7 |
3.83 |
echocardiography |
0.0 |
lad occlusion |
196 |
days |
|
100350 |
2460 |
SS.ZUC-Leprfa-/-/Slc |
heart left ventricle fractional shortening |
everolimus (0.83 mg/kg/d) (for 28 days) |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
heart left ventricle end-diastolic diameter |
male |
91 days
| 12 |
|
38.55 |
% |
1.09 |
3.78 |
echocardiography |
0.0 |
|
0 |
|
|
101808 |
2641 |
SS-Adora2bem2Mcwi |
heart left ventricle fractional shortening |
isoflurane (1-2 %) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
heart left ventricle end-diastolic diameter |
male |
147 days
| 10 |
|
54.3 |
% |
1.4 |
4.43 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
105801 |
3023 |
WKY |
heart left ventricle fractional shortening |
sham surgical control condition (for 224 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
266 days-280 days |
5 |
|
51.5 |
% |
1.7 |
3.8 |
echocardiography |
0.0 |
lad occlusion sham |
210 |
days |
|
100303 |
2460 |
SS/JrSeac |
heart left ventricle fractional shortening |
controlled sodium content diet (0.3 %) (for 84 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart left ventricle end-diastolic diameter |
not specified |
126 days
| 5 |
FS=(EDD−ESD)/EDD |
44.0 |
% |
2.91 |
6.5 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
68577 |
733 |
SS.LEW-(D16Chm36-D16Mit2)/Ayd |
heart left ventricle fractional shortening |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle end-diastolic diameter |
male |
77 days
| 18 |
(LVDdLVDs)/LVDd x 100 |
44.1 |
% |
1.38 |
5.87 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
68285 |
542 |
SS-Nppbem2Mcwi-/- |
heart left ventricle fractional shortening |
control condition (for 168 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
168 days
| 5 |
|
43.4 |
% |
1.5 |
3.35 |
echocardiography |
0.0 |
|
0 |
|
|
99640 |
2319 |
SS/NEisSlc |
heart left ventricle fractional shortening |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) then vehicle control condition (for 49 days) |
Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. |
heart left ventricle end-diastolic diameter |
male |
126 days
| 8 |
|
24.8 |
% |
1.2 |
3.39 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
102317 |
2684 |
Crl:WI |
heart left ventricle fractional shortening |
control condition |
Devanathan S, et al., PLoS One. 2013 Oct 21;8(10):e78477. doi: 10.1371/journal.pone.0078477. eCollection 2013. |
heart left ventricle end-diastolic diameter |
male |
168 days
| 4 |
|
43.45 |
% |
1.78 |
3.56 |
echocardiography |
0.0 |
|
0 |
|
|
103119 |
2786 |
GK/CskCrljCrl |
heart left ventricle fractional shortening |
control condition |
Devanathan S, et al., PLoS One. 2013 Oct 21;8(10):e78477. doi: 10.1371/journal.pone.0078477. eCollection 2013. |
heart left ventricle end-diastolic diameter |
male |
168 days
| 4 |
|
38.2 |
% |
4.45 |
8.89 |
echocardiography |
0.0 |
|
0 |
|
|
103120 |
2786 |
SD |
heart left ventricle fractional shortening |
sham surgical control condition (for 2 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
72 days
| 5 |
|
41.0 |
% |
2.0 |
4.47 |
echocardiography |
0.0 |
sham ACF |
2 |
days |
ledd/pw |
99363 |
2278 |
SD |
heart left ventricle fractional shortening |
artificial aortocaval fistula (for 2 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
72 days
| 5 |
|
48.0 |
% |
5.0 |
11.18 |
echocardiography |
0.0 |
ACF |
2 |
days |
ledd/pw |
99364 |
2278 |
SD |
heart left ventricle fractional shortening |
artificial aortocaval fistula (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
98 days
| 8 |
|
37.0 |
% |
1.0 |
2.83 |
echocardiography |
0.0 |
ACF |
28 |
days |
|
99368 |
2278 |
SS-Nppbem2Mcwi-/- |
heart left ventricle fractional shortening |
gene transfer of the rat natriuretic peptide B gene using an adenovirus vector (100000000000 PFU) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
84 days
| 6 |
|
44.3 |
% |
2.9 |
7.1 |
echocardiography |
0.0 |
|
0 |
|
|
99805 |
2319 |
SS-Nppbem2Mcwi-/- |
heart left ventricle fractional shortening |
vehicle control condition |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
168 days
| 7 |
|
44.3 |
% |
2.8 |
7.41 |
echocardiography |
0.0 |
|
0 |
|
|
99806 |
2319 |
SS.ZUC-Leprfa+/+/Slc |
heart left ventricle fractional shortening |
everolimus (0.83 mg/kg/d) (for 28 days) |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
heart left ventricle end-diastolic diameter |
male |
91 days
| 10 |
|
35.33 |
% |
1.87 |
5.91 |
echocardiography |
0.0 |
|
0 |
|
|
101806 |
2641 |
SS.ZUC-Leprfa-/-/Slc |
heart left ventricle fractional shortening |
vehicle control condition (0.5 %) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
heart left ventricle end-diastolic diameter |
male |
91 days
| 13 |
|
47.66 |
% |
2.43 |
8.76 |
echocardiography |
0.0 |
|
0 |
|
|
102007 |
2644 |
SBH/Ygl |
heart left ventricle fractional shortening |
controlled sodium chloride content diet (0.65 %) (for 98 days) |
Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040. |
heart left ventricle end-diastolic diameter |
male |
98 days
| 7 |
|
66.0 |
% |
1.0 |
2.65 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
106712 |
3038 |
SS-Adora2bem2Mcwi |
heart left ventricle fractional shortening |
isoflurane (1-2 %) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
heart left ventricle end-diastolic diameter |
male |
49 days-56 days |
7 |
|
49.0 |
% |
2.3 |
6.09 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
105827 |
3023 |
SD-Myh7bem1Blar+/- |
heart left ventricle fractional shortening |
control condition |
Chen P, etal., Sci China Life Sci. 2020 Sep;63(9):1347-1362. doi: 10.1007/s11427-019-1627-y. Epub 2020 Mar 17. |
heart left ventricle end-diastolic diameter |
not specified |
84 days
| 0 |
|
84.34 |
% |
11.12 |
|
echocardiography |
0.0 |
|
0 |
|
|
110947 |
3192 |
SS/JrSeac |
heart left ventricle fractional shortening |
controlled sodium content diet (8 %) (for 35 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart left ventricle end-diastolic diameter |
not specified |
77 days
| 5 |
FS=(EDD−ESD)/EDD |
57.0 |
% |
2.64 |
5.9 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
68576 |
733 |
SS.ZUC-Leprfa-/-/Slc |
heart left ventricle fractional shortening |
atorvastatin (6 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
heart left ventricle end-diastolic diameter |
male |
91 days
| 13 |
|
43.53 |
% |
1.18 |
4.25 |
echocardiography |
0.0 |
|
0 |
|
|
102008 |
2644 |
SS-Nppbem2Mcwi-/- |
heart left ventricle fractional shortening |
vehicle control condition |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
84 days
| 7 |
|
47.3 |
% |
4.1 |
10.85 |
echocardiography |
0.0 |
|
0 |
|
|
99804 |
2319 |
SR/NEisSlc |
heart left ventricle fractional shortening |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) |
Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. |
heart left ventricle end-diastolic diameter |
male |
126 days
| 8 |
|
52.6 |
% |
0.7 |
1.98 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
102316 |
2684 |
SS-Nppbem2Mcwi-/- |
heart left ventricle fractional shortening |
vehicle control condition |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
252 days
| 7 |
|
41.6 |
% |
5.6 |
14.82 |
echocardiography |
0.0 |
|
0 |
|
|
99808 |
2319 |
SS.SR-(D3Arb14-D3Mco36)/Mco |
heart left ventricle fractional shortening |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 29 days) then controlled sodium content diet (4 %) (between 40 and 41 days) |
Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2. |
heart left ventricle end-diastolic diameter |
male |
109 days-112 days |
7 |
|
54.0 |
% |
3.0 |
7.94 |
transthoracic echocardiography |
0 |
|
0 |
|
|
65750 |
283 |
SS.LEW-(D3Rat52-D3Chm57)/Ayd |
heart left ventricle fractional shortening |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle end-diastolic diameter |
male |
77 days
| 8 |
(LVDdLVDs)/LVDd x 100 |
48.3 |
% |
1.82 |
5.15 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
68288 |
542 |
SS-Nppbem2Mcwi-/- |
heart left ventricle fractional shortening |
control condition (for 252 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
252 days
| 5 |
|
38.8 |
% |
2.6 |
5.81 |
echocardiography |
0.0 |
|
0 |
|
|
99642 |
2319 |
SD |
heart left ventricle fractional shortening |
sham surgical control condition (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
98 days
| 7 |
|
38.0 |
% |
2.0 |
5.29 |
echocardiography |
0.0 |
sham ACF |
28 |
days |
|
99367 |
2278 |
SS.ZUC-Leprfa+/+/Slc |
heart left ventricle fractional shortening |
bilateral ovariectomy (for 42 days) then 17 beta-estradiol (0.5 mg) (for 35 days) |
Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23. |
heart left ventricle end-diastolic diameter |
female |
91 days
| 12 |
|
55.2 |
% |
1.9 |
6.58 |
echocardiography |
0.0 |
ovariectomy |
42 |
days |
|
101720 |
2622 |
SS.ZUC-Leprfa-/-/Slc |
heart left ventricle fractional shortening |
bilateral ovariectomy (for 42 days) then 17 beta-estradiol (0.5 mg) (for 35 days) |
Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23. |
heart left ventricle end-diastolic diameter |
female |
91 days
| 7 |
|
61.3 |
% |
2.7 |
7.14 |
echocardiography |
0.0 |
ovariectomy |
42 |
days |
|
101722 |
2622 |
SD |
heart left ventricle fractional shortening |
artificial aortocaval fistula (for 105 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
175 days
| 10 |
|
34.0 |
% |
2.0 |
6.32 |
echocardiography |
0.0 |
ACF |
105 |
days |
|
99258 |
2278 |
SD-Myh7bem1Blar-/- |
heart left ventricle fractional shortening |
control condition |
Chen P, etal., Sci China Life Sci. 2020 Sep;63(9):1347-1362. doi: 10.1007/s11427-019-1627-y. Epub 2020 Mar 17. |
heart left ventricle end-diastolic diameter |
not specified |
84 days
| 0 |
|
81.02 |
% |
10.01 |
|
echocardiography |
0.0 |
|
0 |
|
|
110946 |
3192 |
SS.SR-(D7Mco19-D7Mco7)/Jr |
heart left ventricle fractional shortening |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 29 days) then controlled sodium content diet (4 %) (between 40 and 41 days) |
Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2. |
heart left ventricle end-diastolic diameter |
male |
109 days-112 days |
4 |
|
40.0 |
% |
3.0 |
6.0 |
transthoracic echocardiography |
0 |
|
0 |
|
|
65752 |
283 |
SS.LEW-(D18Chm41-D18Rat92)/Ayd |
heart left ventricle fractional shortening |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle end-diastolic diameter |
male |
77 days
| 8 |
(LVDdLVDs)/LVDd x 100 |
49.1 |
% |
1.13 |
3.19 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
68284 |
542 |
SR |
heart left ventricle fractional shortening |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 84 days) |
Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. |
heart left ventricle end-diastolic diameter |
male |
126 days
| 6 |
|
33.0 |
% |
1.63 |
4.0 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
103319 |
2803 |
SS-Nppbem2Mcwi-/- |
heart left ventricle fractional shortening |
controlled sodium content diet (for 21 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
98 days
| 4 |
|
47.0 |
% |
1.41 |
2.82 |
echocardiography |
0.0 |
|
0 |
|
|
99725 |
2319 |
SR |
heart left ventricle fractional shortening |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 42 days) |
Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. |
heart left ventricle end-diastolic diameter |
male |
84 days
| 6 |
|
32.0 |
% |
2.45 |
6.0 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
103317 |
2803 |
SS |
heart left ventricle fractional shortening |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 84 days) |
Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. |
heart left ventricle end-diastolic diameter |
male |
126 days
| 6 |
|
26.0 |
% |
1.22 |
3.0 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
103318 |
2803 |
SS-Nppbem2Mcwi+/+ |
heart left ventricle fractional shortening |
control condition (for 56 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
56 days
| 5 |
|
48.0 |
% |
3.9 |
8.72 |
echocardiography |
0.0 |
|
0 |
|
|
99635 |
2319 |
SS-Nppbem2Mcwi+/+ |
heart left ventricle fractional shortening |
control condition (for 168 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
168 days
| 5 |
|
46.8 |
% |
1.2 |
2.68 |
echocardiography |
0.0 |
|
0 |
|
|
99639 |
2319 |
SS/NEisSlc |
heart left ventricle fractional shortening |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) then tolvaptan (0.05 %) (for 49 days) |
Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. |
heart left ventricle end-diastolic diameter |
male |
126 days
| 8 |
|
44.3 |
% |
1.0 |
2.83 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
102318 |
2684 |
SS-Nppbem2Mcwi+/+ |
heart left ventricle fractional shortening |
controlled sodium content diet (for 21 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
98 days
| 4 |
|
41.7 |
% |
2.62 |
5.24 |
echocardiography |
0.0 |
|
0 |
|
|
99724 |
2319 |
SS-Nppbem2Mcwi+/+ |
heart left ventricle fractional shortening |
control condition (for 252 days) |
Holditch SJ, et al., Sci Rep. 2016 May 10;6:25623. doi: 10.1038/srep25623. |
heart left ventricle end-diastolic diameter |
female |
252 days
| 4 |
|
49.5 |
% |
2.2 |
4.4 |
echocardiography |
0.0 |
|
0 |
|
|
101655 |
2621 |
SD |
heart left ventricle fractional shortening |
sham surgical control condition (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
98 days
| 8 |
|
38.0 |
% |
4.0 |
11.31 |
echocardiography |
0.0 |
sham ACF |
28 |
days |
|
99255 |
2278 |
SD |
heart left ventricle fractional shortening |
artificial aortocaval fistula (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
98 days
| 8 |
|
38.0 |
% |
2.0 |
5.66 |
echocardiography |
0.0 |
ACF |
28 |
days |
|
99256 |
2278 |
SD |
heart left ventricle fractional shortening |
sham surgical control condition (for 105 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
175 days
| 10 |
|
40.0 |
% |
1.0 |
3.16 |
echocardiography |
0.0 |
sham ACF |
105 |
days |
|
99257 |
2278 |
SS.ZUC-Leprfa-/-/Slc |
heart left ventricle fractional shortening |
bilateral ovariectomy (for 42 days) then vehicle control condition (for 35 days) |
Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23. |
heart left ventricle end-diastolic diameter |
female |
91 days
| 8 |
|
47.7 |
% |
1.9 |
5.37 |
echocardiography |
0.0 |
ovariectomy |
42 |
days |
|
101721 |
2622 |
SS/JrHsdMcwi |
heart left ventricle fractional shortening |
isoflurane (1-2 %) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
heart left ventricle end-diastolic diameter |
male |
147 days
| 10 |
|
51.0 |
% |
1.2 |
3.79 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
105800 |
3023 |
SS-Adora2bem2Mcwi |
heart left ventricle fractional shortening |
angiotensin II (200 ng/kg/min) (for 28 days) then isoflurane (1-2 %) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
heart left ventricle end-diastolic diameter |
male |
77 days-84 days |
7 |
|
48.2 |
% |
3.5 |
9.26 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
105831 |
3023 |
SD-Myh7bem1Blar+/+ |
heart left ventricle fractional shortening |
control condition |
Chen P, etal., Sci China Life Sci. 2020 Sep;63(9):1347-1362. doi: 10.1007/s11427-019-1627-y. Epub 2020 Mar 17. |
heart left ventricle end-diastolic diameter |
not specified |
84 days
| 0 |
|
72.52 |
% |
16.33 |
|
echocardiography |
0.0 |
|
0 |
|
SD-Myh7bem1Blar+/+ (RS:0005005) |
110945 |
3192 |
SS.LEW-(D10Got112-Igfbp4)/Ayd |
heart left ventricle fractional shortening |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle end-diastolic diameter |
male |
77 days
| 5 |
(LVDdLVDs)/LVDd x 100 |
49.9 |
% |
1.77 |
3.96 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
68287 |
542 |
WKY |
heart left ventricle fractional shortening |
sham surgical control condition (for 196 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
238 days-252 days |
12 |
|
41.1 |
% |
3.0 |
10.39 |
echocardiography |
0.0 |
lad occlusion sham |
196 |
days |
|
100348 |
2460 |
SS-Nppbem2Mcwi+/+ |
heart left ventricle fractional shortening |
control condition (for 28 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
28 days
| 5 |
|
46.0 |
% |
8.4 |
18.78 |
echocardiography |
0.0 |
|
0 |
|
|
99633 |
2319 |
SS.LEW-(D16Rat112-D16Chm60)/Ayd |
heart left ventricle fractional shortening |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle end-diastolic diameter |
male |
77 days
| 14 |
(LVDdLVDs)/LVDd x 100 |
50.0 |
% |
1.51 |
5.66 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
68286 |
542 |
SS |
heart left ventricle fractional shortening |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 42 days) |
Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. |
heart left ventricle end-diastolic diameter |
male |
84 days
| 7 |
|
32.0 |
% |
1.89 |
5.0 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
103316 |
2803 |
SS-Nppbem2Mcwi-/- |
heart left ventricle fractional shortening |
control condition (for 252 days) |
Holditch SJ, et al., Sci Rep. 2016 May 10;6:25623. doi: 10.1038/srep25623. |
heart left ventricle end-diastolic diameter |
female |
252 days
| 5 |
|
47.4 |
% |
2.4 |
5.37 |
echocardiography |
0.0 |
|
0 |
|
|
101656 |
2621 |
SS-Nppbem2Mcwi+/+ |
heart left ventricle fractional shortening |
control condition (for 84 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
84 days
| 6 |
|
47.0 |
% |
2.1 |
5.14 |
echocardiography |
0.0 |
|
0 |
|
|
99637 |
2319 |
SD |
heart left ventricle fractional shortening |
artificial aortocaval fistula (for 2 days) then Aprotinin (12000 kIU) (for 2 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
72 days
| 5 |
|
50.0 |
% |
3.0 |
6.71 |
echocardiography |
0.0 |
ACF |
2 |
days |
|
99366 |
2278 |
SD |
heart left ventricle fractional shortening |
artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
98 days
| 8 |
|
39.0 |
% |
1.0 |
2.83 |
echocardiography |
0.0 |
ACF |
28 |
days |
|
99369 |
2278 |
SD |
heart left ventricle fractional shortening |
artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
98 days
| 8 |
|
43.0 |
% |
1.0 |
2.83 |
echocardiography |
0.0 |
ACF |
28 |
days |
|
99370 |
2278 |
SS-Nppbem2Mcwi-/- |
heart left ventricle fractional shortening |
gene transfer of the rat natriuretic peptide B gene using an adenovirus vector (100000000000 PFU) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
168 days
| 6 |
|
46.0 |
% |
8.3 |
20.33 |
echocardiography |
0.0 |
|
0 |
|
|
99807 |
2319 |
WKY |
heart left ventricle fractional shortening |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
266 days-280 days |
16 |
|
16.8 |
% |
1.6 |
6.4 |
echocardiography |
0.0 |
lad occlusion |
210 |
days |
|
100304 |
2460 |
WKY |
heart left ventricle fractional shortening |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
266 days-280 days |
32 |
|
18.0 |
% |
1.5 |
8.49 |
echocardiography |
0.0 |
lad occlusion |
210 |
days |
|
100305 |
2460 |
SS.ZUC-Leprfa-/-/Slc |
heart left ventricle fractional shortening |
atorvastatin (20 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
heart left ventricle end-diastolic diameter |
male |
91 days
| 13 |
|
44.28 |
% |
1.6 |
5.77 |
echocardiography |
0.0 |
|
0 |
|
|
102009 |
2644 |
SS.ZUC-Leprfa-/-/Slc |
heart left ventricle fractional shortening |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
heart left ventricle end-diastolic diameter |
male |
91 days
| 7 |
|
44.43 |
% |
1.71 |
4.52 |
echocardiography |
0.0 |
|
0 |
|
|
101807 |
2641 |
SBH/Ygl |
heart left ventricle fractional shortening |
controlled sodium chloride content diet (8 %) (for 42 days) |
Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040. |
heart left ventricle end-diastolic diameter |
male |
98 days
| 7 |
|
64.0 |
% |
2.0 |
5.29 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
106713 |
3038 |
SBH/Ygl |
heart left ventricle fractional shortening |
controlled sodium chloride content diet (0.65 %) (for 98 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 42 days) |
Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040. |
heart left ventricle end-diastolic diameter |
male |
98 days
| 7 |
|
61.0 |
% |
4.0 |
10.58 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
106714 |
3038 |
SS/JrHsdMcwi |
heart left ventricle fractional shortening |
isoflurane (1-2 %) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
heart left ventricle end-diastolic diameter |
male |
49 days-56 days |
5 |
|
48.0 |
% |
1.2 |
2.68 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
105826 |
3023 |
SS-Adora2bem2Mcwi |
heart left ventricle fractional shortening |
angiotensin II (200 ng/kg/min) (for 14 days) then isoflurane (1-2 %) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
heart left ventricle end-diastolic diameter |
male |
63 days-70 days |
7 |
|
51.2 |
% |
3.3 |
8.73 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
105829 |
3023 |
SS/JrHsdMcwi |
heart left ventricle fractional shortening |
angiotensin II (200 ng/kg/min) (for 28 days) then isoflurane (1-2 %) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
heart left ventricle end-diastolic diameter |
male |
77 days-84 days |
5 |
|
51.9 |
% |
3.7 |
8.27 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
105830 |
3023 |
LEW |
heart left ventricle fractional shortening |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle end-diastolic diameter |
male |
77 days
| 14 |
(LVDdLVDs)/LVDd x 100 |
48.6 |
% |
1.21 |
4.54 |
transthoracic echocardiography |
0.0 |
|
0 |
|
heart left ventricle anterior wall thickness |
68281 |
542 |
SD |
heart left ventricle fractional shortening |
sham surgical control condition (for 2 days) then Aprotinin (12000 kIU) (for 2 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
72 days
| 5 |
|
43.0 |
% |
2.0 |
4.47 |
echocardiography |
0.0 |
sham ACF |
2 |
days |
|
99365 |
2278 |
SS-Nppbem2Mcwi+/+ |
heart left ventricle fractional shortening |
control condition (for 252 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
252 days
| 6 |
|
39.0 |
% |
2.2 |
5.39 |
echocardiography |
0.0 |
|
0 |
|
|
99641 |
2319 |